Methods for droplet-based sample preparation

US9695468B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9695468-B2
Application numberUS-201514624473-A
CountryUS
Kind codeB2
Filing dateFeb 17, 2015
Priority dateAug 14, 2012
Publication dateJul 4, 2017
Grant dateJul 4, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

This disclosure provides microwell capsule array devices. The microwell capsule array devices are generally capable of performing one or more sample preparation operations. Such sample preparation operations may be used as a prelude to one more or more analysis operations. For example, a device of this disclosure can achieve physical partitioning and discrete mixing of samples with unique molecular identifiers within a single unit in preparation for various analysis operations. The device may be useful in a variety of applications and most notably nucleic-acid-based sequencing, detection and quantification of gene expression and single-cell analysis.

First claim

Opening claim text (preview).

What is claimed is: 1. A method for droplet generation, comprising: (a) providing at least 1,000,000 oligonucleotide molecules comprising barcode sequences, wherein said barcode sequences are the same sequence for said at least 1,000,000 oligonucleotide molecules, wherein said at least 1,000,000 oligonucleotide molecules are releasably attached to a bead, wherein said bead is porous; (b) combining said at least 1,000,000 oligonucleotide molecules and a sample comprising a nucleic acid analyte each in an aqueous phase at a first junction of two or more channels of a microfluidic device to form an aqueous mixture comprising said at least 1,000,000 oligonucleotide molecules attached to said bead and said sample; and (c) generating a droplet comprising said at least 1,000,000oligonucleotide molecules attached to said bead and said sample comprising said nucleic acid analyte by contacting said aqueous mixture with an immiscible continuous phase at a second junction of two or more channels of said microfluidic device. 2. The method of claim 1 , further comprising, in (b), combining said at least 1,000,000 oligonucleotide molecules attached to said bead, said nucleic acid analyte and one or more reagents necessary for amplification of said nucleic acid analyte at said first junction to form said aqueous mixture comprising said at least 1,000,000 oligonucleotide molecules attached to said bead, said nucleic acid analyte and said one or more reagents. 3. The method of claim 2 , wherein in (c), said droplet further comprises said one or more reagents. 4. The method of claim 3 , wherein said one or more reagents comprises a polymerase. 5. The method of claim 4 , wherein said polymerase is unable to recognize uracil. 6. The method of claim 1 , wherein said bead comprises a polyacrylamide. 7. The method of claim 1 , wherein said bead is a gel bead. 8. The method of claim 1 , wherein said at least 1,000,000 oligonucleotide molecules comprise uracil. 9. The method of claim 1 , wherein a given oligonucleotide molecule of said at least 1,000,000 oligonucleotide molecules comprises a region which functions as a primer. 10. The method of claim 9 , wherein said region which functions as said primer has a sequence for random priming. 11. The method of claim 9 , further comprising, after (c), amplifying said nucleic acid analyte with said primer. 12. The method of claim 1 , wherein said nucleic acid analyte is selected from the group consisting of deoxyribonucleic acid (DNA), ribonucleic acid (RNA), amplicons, synthetic polynucleotides, polynucleotides, oligonucleotides, cDNA, dsDNA, ssDNA, plasmid DNA, cosmid DNA, High Molecular Weight (MW) DNA, chromosomal DNA, genomic DNA, viral DNA, bacterial DNA, mtDNA (mitochondrial DNA), mRNA, rRNA, tRNA, nRNA, siRNA, snRNA, snoRNA, scaRNA, microRNA, dsRNA, ribozyme, riboswitch and viral RNA. 13. The method of claim 1 , wherein said at least 1,000,000 oligonucleotide molecules are attached to said bead via a chemical cross-linker. 14. The method of claim 1 , wherein said at least 1,000,000 oligonucleotide molecules are attached to said bead via a disulfide bond. 15. The method of claim 1 , wherein said at least 1,000,000 oligonucleotide molecules are attached to said bead via a covalent bond. 16. The method of claim 1 , wherein said at least 1,000,000 oligonucleotide molecules are attached to said bead via a labile moiety. 17. The method of claim 1 , wherein said bead is degradable upon application of a stimulus. 18. The method of claim 17 , further comprising applying said stimulus to the droplet to release said at least 1,000,000 oligonucleotide molecules from said bead into said droplet. 19. The method of claim 18 , wherein said stimulus is selected from the group consisting of a biological stimulus, a chemical stimulus, a thermal stimulus, an electrical stimulus, a magnetic stimulus, and a photo stimulus. 20. The method of claim 19 , wherein said stimulus is a chemical stimulus that is a reducing agent. 21. The method of claim 1 , wherein subsequent to generating said droplet in (c), a given oligonucleotide molecule of said at least 1,000,000 oligonucleotide molecules attaches to said nucleic acid analyte, and wherein said given oligonucleotide molecule attached to said given nucleic acid analyte is subjected to nucleic acid amplification to yield a barcoded nucleic acid analyte. 22. The method of claim 1 , wherein said bead comprises a chemical cross-linker. 23. The method of claim 22 , wherein said chemical cross-linker is a disulfide bond.

Assignees

Inventors

Classifications

  • C12Q1/6806Primary

    Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay (C12Q1/6804 takes precedence) · CPC title

  • Microreactors, e.g. emulsion PCR or sequencing, droplet PCR, microcapsules, i.e. non-liquid containers with a range of different permeability's for different reaction components · CPC title

  • phase change valves; Meltable, freezing, dissolvable plugs; Destructible barriers · CPC title

  • Handling flowable solids, e.g. microscopic beads, cells, particles · CPC title

  • Massive parallel sequencing · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9695468B2 cover?
This disclosure provides microwell capsule array devices. The microwell capsule array devices are generally capable of performing one or more sample preparation operations. Such sample preparation operations may be used as a prelude to one more or more analysis operations. For example, a device of this disclosure can achieve physical partitioning and discrete mixing of samples with unique molec…
Who is the assignee on this patent?
10X Genomics Inc
What technology area does this patent fall under?
Primary CPC classification C12Q1/6806. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jul 04 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 12 related publications on this page (citations in our corpus or others sharing the same primary CPC).